Company news
Aelis Farma Sa (EURONEXT:AELIS) news
Aelis Farma Sa news releases on 6ix. Latest, Sep 24, 2026: Aelis Farma: Availability of the 2026 Half-Year Financial Report
Press releases & updates
Aelis Farma: Availability of the 2026 Half-Year Financial Report
September 24, 2026
Aelis Farma Reports 2026 Half-Year Financial Results and Presents Progress and Development Outlook
September 15, 2026
Aelis Farma Receives a Positive Recommendation From the Independent Data Monitoring Committee to Continue the Phase 2b Study of AEF0217 in People With Down Syndrome Without Modification
July 16, 2026
Aelis Farma: Availability of the Description of the Share Buyback Program
June 22, 2026
Results of Aelis Farma Combined General Meeting of June 3, 2026
June 4, 2026
Aelis Farma : Results of Aelis Farma Combined General Meeting of June 3, 2026
June 4, 2026
Aelis Farma: Combined General Meeting of June 3, 2026: Availability of Preparatory Documents and Participation and Voting Procedures
May 13, 2026
Aelis Farma : Availability of documents for the AGM on June 3, 2026
May 13, 2026
Aelis Farma: Availability of the 2025 Universal Registration Document
April 24, 2026
Aelis Farma Awarded a €458k Grant Under France 2030 in Nouvelle-Aquitaine to Support Development of Its Program in Obesity and Associated Metabolic Diseases
April 7, 2026
Aelis Farma : awarded a €458k grant under France 2030
April 6, 2026
Aelis Farma Reports Its 2025 Annual Financial Results and Confirms Its 2026 Outlook
March 30, 2026
Aelis Farma announces the successful start of the recruitment of the Phase 2B clinical trial with AEF0217 for the treatment of behavioral and cognitive impairments of people with Down syndrome (Trisomy 21)
March 21, 2026
Aelis Farma : Successful start of the recruitment of the Phase 2B clinical trial with AEF0217
March 20, 2026
Aelis Farma Announces Its 2026 Financial Calendar
January 26, 2026
Aelis Farma Receives a Positive Opinion From EMA Pediatric Committee on the Pediatric Investigation Plan for AEF0217 in Down Syndrome
January 12, 2026
Aelis Farma : Positive opinion from EMA Pediatric Committee on the Pediatric Investigation Plan for AEF0217
January 11, 2026
Aelis Farma Obtains Regulatory Approval of the Phase 2B Trial With AEF0217 in People With Down Syndrome
December 2, 2025
Aelis Farma : obtains regulatory approval of the Phase 2B trial with AEF0217 in people with Down syndrome
December 1, 2025
Aelis Farma: Availability of the 2025 Half-Year Financial Report
September 25, 2025
Aelis Farma Reports 2025 Half-Year Financial Results and Presents Progress and Development Outlook
September 22, 2025
Aelis Farma : 2025 half-year financial results, progress and development outlook
September 21, 2025
Aelis Farma: Availability of the Description of the Share Buyback Program
June 24, 2025
Results of Aelis Farma Combined General Meeting of May 27, 2025
May 27, 2025
Aelis Farma: Combined General Meeting of May 27, 2025: Availability of Preparatory Documents and Participation and Voting Procedures
May 6, 2025
Aelis Farma: Availability of the 2024 Universal Registration Document
April 29, 2025